Policy commentary analyzes medical legitimacy standards, antimicrobial resistance, and practitioner recognition in India, highlighting systemic challenges.
Background Debates surrounding the legitimacy of AYUSH practitioners, particularly the use of the professional prefix “Dr.” by Bachelor of Ayurvedic Medicine and Surgery (BAMS) graduates, have intensified on social media and professional platforms in India. These discussions frequently invoke concepts such as “evidence-based medicine,” “scientific legitimacy,” and “quackery,” often without equivalent scrutiny of systemic challenges within contemporary healthcare systems. Objective This policy commentary examines the asymmetrical standards applied in debates on medical legitimacy by analyzing antimicrobial resistance (AMR), irrational fixed-dose combinations (FDCs), pharmacovigilance gaps, adverse drug reaction (ADR) reporting, iatrogenic harm, publication bias, and the legal status of AYUSH practitioners in India. Methods A narrative policy analysis was conducted using publicly available sources, including WHO GLASS reports, ICMR antimicrobial resistance surveillance data, CDSCO regulatory notifications, Pharmacovigilance Programme of India (PvPI) reports, statutory provisions under the National Commission for Indian System of Medicine (NCISM) Act, 2020, judicial precedents, and peer-reviewed literature on prescribing behavior, medical error, publication bias, and healthcare regulation. Key Findings The analysis identifies significant challenges within contemporary healthcare systems, including rising antimicrobial resistance, the historical persistence of irrational drug combinations, underreporting of adverse drug reactions, limited transparency regarding iatrogenic harm, and broader concerns regarding overmedicalization and commercial influence. Simultaneously, it highlights the statutory recognition of AYUSH practitioners under Indian law and questions the consistency of applying the label “quack” to legally registered professionals. Conclusion The article argues that criticism of any healthcare system should be accompanied by equivalent scrutiny of one’s own institutional practices. It calls for a more pluralistic, evidence-informed, and self-critical approach to healthcare discourse, emphasizing intellectual humility, transparent risk communication, and symmetrical standards of accountability across all systems of medicine.
No takes yet. Share an insight, caveat, or question.
Akshat Mishra (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: